Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Deloitte
Cipla
Merck
Julphar
Healthtrust
Accenture
Medtronic
Cerilliant
McKesson

Generated: December 12, 2017

DrugPatentWatch Database Preview

MESALAMINE Drug Profile

« Back to Dashboard

When do Mesalamine patents expire, and when can generic versions of Mesalamine launch?

Mesalamine is a drug marketed by G And W Labs Inc, Perrigo Israel, Mylan Pharms Inc, and Zydus Pharms Usa Inc. and is included in five NDAs.

The generic ingredient in MESALAMINE is mesalamine. There are twenty-eight drug master file entries for this compound. Twenty suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the mesalamine profile page.
Drug patent expirations by year for MESALAMINE

Pharmacology for MESALAMINE

Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate

Medical Subject Heading (MeSH) Categories for MESALAMINE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
G And W Labs IncMESALAMINEmesalamineENEMA;RECTAL076841-001Sep 30, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncMESALAMINEmesalamineTABLET, DELAYED RELEASE;ORAL091640-001Jun 5, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Perrigo IsraelMESALAMINEmesalamineENEMA;RECTAL076751-001Sep 17, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncMESALAMINEmesalamineSUPPOSITORY;RECTAL204354-001Nov 24, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncMESALAMINEmesalamineTABLET, DELAYED RELEASE;ORAL203286-001Jul 21, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
McKinsey
Chubb
Cerilliant
AstraZeneca
Fuji
Johnson and Johnson
Merck
McKesson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot